About This Project
Microplastics are found in our food, water, and air, yet their impact on human reproduction remains unknown. We hypothesize that microplastics in blood may be linked to impaired embryo development, reduced semen quality, and lower live birth rates. Our study will directly measure blood microplastics in couples undergoing fertility treatment, correlating levels with reproductive outcomes. This novel research could transform fertility care and highlight a pressing public health concern.
Ask the Scientists
Join The DiscussionWhat is the context of this research?
Microplastics (MP), plastic particles under 5 mm, are now widespread in the environment and pose emerging risks to human health—including reproduction. MPs enter the body via ingestion, inhalation, and skin contact, accumulating in blood, placenta, amniotic fluid, follicular fluid, and even breastmilk. Studies have detected MPs in the ovarian follicular fluid of women undergoing IVF and in placentas and amniotic fluid, raising concerns about their ability to cross biological barriers and affect fetal development. Animal research shows MPs can impair ovarian and sperm function, disrupt hormones, and harm embryo development. In humans, higher levels of plasticizers like phthalates and bisphenols are found in blood, especially among younger women, indicating ongoing exposure. Blood sampling is minimally invasive, routinely performed, and reflects systemic MP exposure, making it a promising biomarker for studying links between environmental exposure, fertility, and IVF outcomes.
What is the significance of this project?
This project addresses a critical public health concern: the impact of microplastics (MPs) on fertility and IVF success. Infertility affects 15–20% of couples, and most IVF cycles do not result in live birth, even for women under 35 (up to 47% per cycle). MPs are now found in food, water, air, and personal care products, accumulating in blood, placenta, and reproductive tissues. MPs can disrupt hormones, induce oxidative stress, and impair ovarian and sperm function, all linked to poor fertility outcomes. Blood testing offers a minimally invasive, standardized way to monitor systemic MP exposure. If we show a correlation between blood MPs and IVF failure, blood MP levels could become a biomarker to guide patient counseling and risk reduction. While proven ways to lower MPs are lacking, strategies include reducing plastic use and exposure. This project could transform fertility care and inform public health policy.
What are the goals of the project?
This project aims to determine if serum microplastic levels correlate with reproductive outcomes—including embryo development, semen quality, clinical pregnancy, and live birth rates—in IVF patients. We will conduct a prospective cohort study of 30 individuals (20 females, 10 males) at our center, with IRB approval and informed consent. Blood samples will be collected at IVF cycle start and analyzed for MPs using mass spectrometry. Female data will include ovarian reserve, hormone profiles, and embryo grading; male data will include sperm concentration, motility, morphology, and DNA fragmentation. Live birth outcomes will be tracked. Multivariate regression will assess links between MP levels and outcomes, adjusting for confounders. Inclusion: females 25–39, BMI 18.5–40, AMH ≥1.0, first IVF, no smoking/vaping, normal uterus, no PCOS, endometriosis, or diminished reserve; males 25–49, BMI 18.5–40, no infertility or tobacco/drug use, no relevant surgeries or exposures.
Budget
My team—including nurses, statisticians, and research assistants—is fully committed to this project. We will write the IRB, consent patients, draw and mail blood samples, and analyze the data ourselves, all without compensation. The $4,000 will cover specialized blood test kits; the $1,000 covers essential overhead like shipping and platform fees. We’re not asking for salaries—we’re asking for the tools to uncover how microplastics may be silently destroying fertility. Help us change the field.
Endorsed by
Project Timeline
Key steps include obtaining IRB approval, timely recruitment, and efficient blood sample collection at IVF cycle start. Rapid and accurate microplastic analysis and data entry are critical. Data interpretation depends on sample quality and participant follow-up. We will pilot this study within 1 month. Manuscript preparation and submission will share results with the scientific community by this fall.
Jul 01, 2025
Project Launched
Jul 14, 2025
Complete all of the blood draws
Aug 11, 2025
Complete analysis and start manuscript preparation
Sep 15, 2025
Finalize and complete manuscript for submission
Meet the Team
Affiliates
Affiliates
Team Bio
Nicholas Stansbury, MD
I am a second-year Reproductive Endocrinology and Infertility fellow at UT Health San Antonio. I am interested in doing simple, relatable, and realistic translational research to change patient care quickly. Join me, now!
Abigail Ellstrom
I am a third-year medical student at Texas Christian University interested in pursuing a career in women's health.
Project Backers
- 0Backers
- 0%Funded
- $0Total Donations
- $0Average Donation